Generative Artificial Intelligence for Retinal Image Translation to Improve Glaucoma Screening With Deep Learning

利用生成式人工智能进行视网膜图像转换,以改进基于深度学习的青光眼筛查

阅读:1

Abstract

PURPOSE: The purpose of this study was to improve automated glaucoma detection by utilizing generative adversarial networks (GANs) to translate underutilized scanning laser ophthalmoscopy (SLO) fundus images into synthetic color fundus (CF) photographs. METHODS: A Cycle-Consistent GAN model (CycleGAN) framework was used to translate 16,936 SLO fundus photographs into corresponding synthetic CF images. Five deep learning models were trained using real CF, synthetic CF, SLO fundus, and combined datasets to classify glaucoma from a holdout test set of real CF photographs. Model performance was evaluated using the area under the operating characteristic curve (AUC) and sensitivity at 90% and 95% specificities. RESULTS: The "GAN+CFP" model, trained on real and synthetic CF images, achieved the highest AUC (0.94, 95% confidence interval [CI] = 0.93-0.96, P < 0.05) and sensitivity at 90% and 95% specificities (0.83 and 0.77, respectively), outperforming the "CFP" (AUC = 0.89, sensitivities = 0.77 and 0.66), "SLO+CFP" (AUC = 0.88, sensitivities = 0.71 and 0.56), and "GAN" models (AUC = 0.82, sensitivities = 0.51 and 0.33). The "GAN+CFP" and "SLO+CFP" models demonstrated consistent sensitivity across racial and ethnic groups, with "GAN+CFP" yielding superior results across demographics. CONCLUSIONS: GANs effectively translate SLO images into synthetic CF photographs, addressing domain shifts and increasing dataset sizes to enhance glaucoma detection. TRANSLATIONAL RELEVANCE: GANs may improve glaucoma classification models by improving dataset consistency and mitigating domain shifts. By generating synthetic CF images from SLO data, GANs expand available training data in a clinically relevant imaging modality.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。